Department of Biochemistry and Molecular Biology, Virginia Commonwealth University School of Medicine, Richmond, Va.
Department of Internal Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine, University of Kentucky College of Medicine, Lexington, Ky.
J Allergy Clin Immunol. 2021 May;147(5):1936-1948.e9. doi: 10.1016/j.jaci.2020.10.024. Epub 2020 Oct 29.
Nothing is known about the mechanisms by which increased ceramide levels in the lung contribute to allergic responses and asthma severity.
We sought to investigate the functional role of ceramide in mouse models of allergic airway disease that recapitulate the cardinal clinical features of human allergic asthma.
Allergic airway disease was induced in mice by repeated intranasal administration of house dust mite or the fungal allergen Alternaria alternata. Processes that can be regulated by ceramide and are important for severity of allergic asthma were correlated with ceramide levels measured by mass spectrometry.
Both allergens induced massive pulmonary apoptosis and also significantly increased reactive oxygen species in the lung. Prevention of increases in lung ceramide levels mitigated allergen-induced apoptosis, reactive oxygen species, and neutrophil infiltration. In contrast, dietary supplementation of the antioxidant α-tocopherol decreased reactive oxygen species but had no significant effects on elevation of ceramide level or apoptosis, indicating that the increases in lung ceramide levels in allergen-challenged mice are not mediated by oxidative stress. Moreover, specific ceramide species were altered in bronchoalveolar lavage fluid from patients with severe asthma compared with in bronchoalveolar lavage fluid from individuals without asthma.
Our data suggest that elevation of ceramide level after allergen challenge contributes to the apoptosis, reactive oxygen species generation, and neutrophilic infiltrate that characterize the severe asthmatic phenotype. Ceramide might be the trigger of formation of Creola bodies found in the sputum of patients with severe asthma and could be a biomarker to optimize diagnosis and to monitor and improve clinical outcomes in this disease.
目前尚不清楚肺部神经酰胺水平升高如何导致过敏反应和哮喘严重程度。
我们试图研究神经酰胺在模拟人类过敏性哮喘主要临床特征的过敏性气道疾病小鼠模型中的功能作用。
通过反复鼻内给予屋尘螨或真菌过敏原 Alternaria alternata ,在小鼠中诱导过敏性气道疾病。通过质谱法测量神经酰胺水平,将可受神经酰胺调节且对过敏性哮喘严重程度很重要的过程与神经酰胺水平相关联。
两种变应原均诱导大量肺部细胞凋亡,并显著增加肺部活性氧。预防肺神经酰胺水平升高可减轻变应原诱导的细胞凋亡、活性氧和中性粒细胞浸润。相比之下,膳食补充抗氧化剂 α-生育酚可降低活性氧,但对神经酰胺水平或细胞凋亡的升高没有显著影响,表明在变应原挑战的小鼠中,肺神经酰胺水平的升高不是由氧化应激介导的。此外,与无哮喘个体的支气管肺泡灌洗液相比,严重哮喘患者的支气管肺泡灌洗液中的特定神经酰胺种类发生了改变。
我们的数据表明,变应原挑战后神经酰胺水平的升高导致了严重哮喘表型的细胞凋亡、活性氧生成和中性粒细胞浸润。神经酰胺可能是 Creola 体形成的触发因素,Creola 体存在于严重哮喘患者的痰液中,可作为生物标志物来优化诊断,并监测和改善该疾病的临床结局。